Page 5 - Michael Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The big news from berkeley. A fire at one of the bay areas best known restaurants. This happening right now in oakland. A major crime sweep involving federal agents and local police. A live report coming up. Overnight news froms. The victim of a horrible Home Invasion robbery is now telling his story. More than 100 people have been living in a homeless camp in san jose. They are supposed to clear out this morning but many are still here. What is going to happen. Mornings on 2 starts now. Complete, bay area News Coverage starts right now this is ktvu mornings on 2. Good morning. Welcome to morn...

Quijano good evening. Im Elaine Quijano. This is our western edition. Trump Administration Efforts to further isolate north korea may be working. Today, china urged its outcast neighbor to make a smart decision and stop conducting missile launches and nuclear tests. The scolding follows the passage of a u. S. Resolution at the u. N. Security council that imposes tough new sanctions on the regime, that could cost the country a billion dollars in lost trade. Errol barnett has the latest. Reporter President Trump says hes working during his stay at his golf club in bedminister, but he took time y...

Particularly outside hong kong but this here that is radically different. Im melissa chan welcome to news asia thank you for joining us the European Parliament has awarded its pristine just human rights award the soccer prize to iran toady he is the professor and member of the ethnic Muslim Minority called weekers who mostly live in china beijing has gone after this group putting an estimated 1000000 of them according to the u. N. In detention camps yes you heard that right detention camps its the largest internment of people since world war 2 toady is serving a life sentence he probably doesn...

The FDA has approved Breyanzi (lisocabtagene maraleucel) for the treatment of previously treated adults with relapsed or refractory mantle cell lymphoma.

The FDA has approved Breyanzi (lisocabtagene maraleucel) for the treatment of previously treated adults with relapsed or refractory mantle cell lymphoma.